Moraxella catarrhalis is a bacterial species that inhabits the human upper respiratory tract and can cause respiratory disease. It is an important cause of middle-ear infection in children and contributes to sinus infections and exacerbations of chronic obstructive pulmonary disease in adults. Its presence in a respiratory specimen does not necessarily indicate infection, because asymptomatic carriage is common, particularly in young children.
Classification and biological characteristics
M. catarrhalis belongs to the genus Moraxella in the family Moraxellaceae. Historically, it was classified under several other genera, including Micrococcus, Neisseria, and Branhamella. The name Branhamella catarrhalis therefore appears frequently in older medical literature. Its earlier placement among the neisseriae reflected similarities in microscopic appearance and laboratory characteristics.
The organism is a Gram-negative, nonmotile coccus, usually occurring in pairs known as diplococci. It does not form spores and is generally described as aerobic. Its cell envelope includes an outer membrane and a thin layer of peptidoglycan, characteristic of Gram-negative bacteria.
M. catarrhalis is oxidase-positive and catalase-positive. It is also asaccharolytic: it does not produce acid from the carbohydrates used in conventional diagnostic fermentation tests. Its metabolism instead draws on other substrates, including organic acids and amino acids.
On suitable culture media, colonies are typically smooth, opaque, and grayish-white. A characteristic laboratory observation is that an intact colony may slide across the agar surface when pushed, sometimes called the “hockey-puck” sign. This feature is supportive rather than sufficient for identification.
Carriage and transmission
Humans are the principal reservoir of M. catarrhalis. The bacterium commonly colonizes the nasopharynx without causing symptoms. Carriage is generally more frequent in infants and young children than in healthy adults, although reported rates depend on age, setting, season, and sampling method.
Spread occurs through contact with respiratory secretions. Acquisition of a strain may result in transient carriage, prolonged colonization, or symptomatic infection. In people with chronic obstructive pulmonary disease, acquisition of a new strain has been associated with some acute exacerbations, but acquisition does not invariably cause illness.
The distinction between colonization and disease is central to its epidemiology. Detecting the organism establishes its presence, not necessarily its responsibility for a patient’s symptoms.
Mechanisms of disease
M. catarrhalis uses surface proteins to attach to respiratory epithelial cells and interact with host molecules. These include members of the ubiquitous surface protein family, commonly abbreviated UspA. Several surface components contribute to resistance against the complement system, a group of host proteins involved in antimicrobial defense.
The organism can form biofilms, organized bacterial communities associated with a surface and an extracellular matrix. Biofilm growth is relevant to persistence in the respiratory tract and middle ear, where M. catarrhalis may coexist with other organisms.
Its outer membrane contains lipooligosaccharide, which can stimulate innate immune responses and contribute to inflammation. Infection therefore reflects interactions among bacterial adhesion, persistence, immune evasion, and the host inflammatory response rather than the action of a single toxin.
Associated diseases
The principal clinical associations are:
- Acute otitis media: M. catarrhalis is one of the major bacterial causes of middle-ear infection in children, alongside Streptococcus pneumoniae and nontypeable Haemophilus influenzae.
- Acute bacterial sinusitis: it can infect the paranasal sinuses, particularly in children.
- Exacerbations of chronic obstructive pulmonary disease: it is an established bacterial contributor to episodes of worsening respiratory symptoms.
- Pneumonia and other lower respiratory infections: these occur especially in older adults and people with underlying respiratory disease.
Invasive infections, including bloodstream infection, meningitis, and endocarditis, have been reported but are uncommon. Although M. catarrhalis was once often regarded as a harmless respiratory commensal, its role as a pathogen is well established.
Laboratory identification and interpretation
Laboratory diagnosis may involve culture, biochemical identification, mass spectrometry, or molecular methods. Conventional identification combines microscopic appearance with tests such as oxidase activity, DNase production, and butyrate esterase activity. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry is widely used for bacterial identification. Polymerase chain reaction assays can detect specific bacterial DNA sequences.
Interpretation depends on the source and quality of the specimen. A positive upper-airway swab can reflect carriage. Sputum may contain organisms originating from the upper airway, so its findings require clinical and microscopic context. Recovery from blood or another normally sterile site has a different significance from detection in a nasopharyngeal specimen.
Antimicrobial resistance
Most contemporary clinical isolates produce a beta-lactamase, an enzyme that breaks down certain beta-lactam antibiotics. The characteristic enzymes are designated BRO-1 and BRO-2. Their widespread occurrence makes susceptibility to unprotected penicillins, such as ampicillin or amoxicillin, unreliable.
Beta-lactamase production does not imply resistance to every beta-lactam antibiotic, and resistance to other antimicrobial classes varies geographically and over time. Laboratory susceptibility results and local surveillance data describe these patterns more accurately than species identification alone. Antimicrobial resistance is distinct from virulence: resistance affects drug activity, whereas virulence concerns the organism’s capacity to cause disease.